Dipyridamol antiplatelets drug

dipyridamol monoacetate - dipyridamole monoacetate



Trial Studied treatment Control Patients Size Study type Results NCT

Acute coronary syndrome - antithrombotics in all type of patients - antiplatelets drug in ACS (excluding AMI) - antiplatelets drug in all type of patients

Prandoni, 1991aspirin + dipyridamolplacebo88 (44/44)

CABG surgery - antiplatelets drug in all type of patients

Pantely, 1979aspirin + dipyridamolcontrol48 (18/30)
Brussels, 1987aspirin + dipyridamolcontrol49 (24/25)
Czech, 1986aspirin + dipyridamolcontrol93 (47/46)
Des Moines, 1980aspirin + dipyridamolcontrol114 (60/54)
GESIC (aspirin+dipyridamol), 1990aspirin + dipyridamolplacebo739 (368/371)
Brooks, 1985aspirin + dipyridamolplacebo320 (160/160)
Mayo-A, 1984aspirin + dipyridamolplacebo407 (202/205)
Wadsworth, 1985aspirin + dipyridamolplacebo198 (96/102)
Basel, 1989aspirin + dipyridamolplacebo125 (62/63)
Leeds-B, 1985aspirin + dipyridamolplacebo125 (61/64)
Thaulow, 1987aspirin + dipyridamolplacebo69 (34/35)
Toronto dipyridamole, 1987dipyridamolcontrol40 (20/20)
Ekestrom, 1990dipyridamolplacebo360 (174/186)

Cardiovascular prevention - antiplatelets drug in secondary prevention in patients with CAD - antiplatelets drug in secondary prevention in patients with intermittent claudication

Hess (2), 1985aspirin + dipyridamolplacebo160 (80/80)
Schoop (2), 1983aspirin + dipyridamolplacebo200 (100/100)
VA study, 1986aspirin + dipyridamolplacebo231 (110/121)
Atlanta (Sbar), 1967dipyridamolcontrol60 (30/30) Exploratory
Wirecki, 1967dipyridamolcontrol56 (28/28) Exploratory
Becker, 1967dipyridamolcontrol27 (14/13) Exploratory
Kinsella, 1962dipyridamolplacebo26 (13/13) Exploratory
Leiberman, 1964dipyridamolplacebo38 (19/19) Exploratory
Zion, 1961dipyridamolplacebo28 (14/14) Exploratory
Dewar, 1961dipyridamolplacebo34 (17/17) Exploratory
Neumann, 1964dipyridamolplacebo36 (20/16) Exploratory
Foulds, 1960dipyridamolplacebo48 (24/24) Exploratory
Igloe, 1970dipyridamolplacebo48 (26/22) Exploratory
PARIS, 1980dipyridamol + aspirinaspirin1620 (810/810)
PARIS, 1980dipyridamol + aspirinplacebo1216 (810/406)
PARIS-II, 1986dipyridamol + aspirinplacebo3128 (1563/1565)

Coronary artery disease - death and events prevention in all type of patients

Atlanta (Sbar), 1967dipyridamolcontrol60 (30/30) Exploratory
Wirecki, 1967dipyridamolcontrol56 (28/28) Exploratory
Becker, 1967dipyridamolcontrol27 (14/13) Exploratory
Kinsella, 1962dipyridamolplacebo26 (13/13) Exploratory
Leiberman, 1964dipyridamolplacebo38 (19/19) Exploratory
Zion, 1961dipyridamolplacebo28 (14/14) Exploratory
Dewar, 1961dipyridamolplacebo34 (17/17) Exploratory
Neumann, 1964dipyridamolplacebo36 (20/16) Exploratory
Foulds, 1960dipyridamolplacebo48 (24/24) Exploratory
Igloe, 1970dipyridamolplacebo48 (26/22) Exploratory
PARIS, 1980dipyridamol + aspirinaspirin1620 (810/810)
PARIS, 1980dipyridamol + aspirinplacebo1216 (810/406)
PARIS-II, 1986dipyridamol + aspirinplacebo3128 (1563/1565)

Percutaneous coronary intervention - antithrombotics in all type of patients

Schwartz (Toronto), 1988aspirin + dipyridamolplacebo376 (187/189)
White (aspirin+dipiridamol), 1991aspirin + dipyridamolplacebo499 (245/254)
Nye (Dunedin), 1990aspirin + dipyridamolplacebo72 (35/37)
Mayo-PTCA, 1989aspirin + dipyridamolplacebo207 (102/105)

Peripheral vascular diseases - antiplatelets drug in all type of patient

Hess (2), 1985aspirin + dipyridamolplacebo160 (80/80)
Schoop (2), 1983aspirin + dipyridamolplacebo200 (100/100)
VA study, 1986aspirin + dipyridamolplacebo231 (110/121)

Post myocardial infarction - antiplatelets drug in all type of patient - secondary prevention in all type of patients

PARIS, 1980dipyridamol + aspirinaspirin1620 (810/810)
PARIS, 1980dipyridamol + aspirinplacebo1216 (810/406)
PARIS-II, 1986dipyridamol + aspirinplacebo3128 (1563/1565)

Stable angina - antithrombotics in all type of patient

Atlanta (Sbar), 1967dipyridamolcontrol60 (30/30) Exploratory
Wirecki, 1967dipyridamolcontrol56 (28/28) Exploratory
Becker, 1967dipyridamolcontrol27 (14/13) Exploratory
Kinsella, 1962dipyridamolplacebo26 (13/13) Exploratory
Leiberman, 1964dipyridamolplacebo38 (19/19) Exploratory
Zion, 1961dipyridamolplacebo28 (14/14) Exploratory
Dewar, 1961dipyridamolplacebo34 (17/17) Exploratory
Neumann, 1964dipyridamolplacebo36 (20/16) Exploratory
Foulds, 1960dipyridamolplacebo48 (24/24) Exploratory
Igloe, 1970dipyridamolplacebo48 (26/22) Exploratory

Thrombosis prevention - antithrombotics in general surgery - antiplatelets drug in general surgery - antiplatelets drug in all type of patients - antithrombotics in orthopedic surgery - antiplatelets drug in orthopedic surgery - antiplatelets drug in elective orthopedic surgery - antithrombotics in medical patients - antiplatelets drug in medical patients

Chicago, 1982aspirin + dipyridamolcontrol27 (12/15) Exploratory
Morris-B , 1977aspirin + dipyridamolno treatment64 (32/32) Exploratory
Lyon-I, 1975aspirin + dipyridamolno treatment40 (20/20) Exploratory
Encke-II , 1976aspirin + dipyridamolplacebo59 (34/25) Exploratory
Hamburg, 1976aspirin + dipyridamolplacebo32 (21/11) Exploratory
Frankfurt, 1981aspirin + dipyridamolplacebo39 (25/14) Exploratory
Morris-A , 1977dipyridamolno treatment48 (24/24) Exploratory
Parodi I, 1973dipyridamol + aspirincontrol62 (40/22) Exploratory
Parodi II, 1973dipyridamol + aspirincontrol126 (91/35) Confirmatory -
Australian I, 1975dipyridamol + aspirincontrol150 (75/75) Confirmatory -
Australian II, 1976dipyridamol + aspirincontrol160 (85/75) Confirmatory -
Toulouse I, 1979dipyridamol + aspirincontrol104 (38/66) Confirmatory -
Zekert-III, 1977dipyridamol + aspirincontrol181 (135/46) Confirmatory -
Harjola DVT, 1982dipyridamol + aspirincontrol400 (300/100) Confirmatory -
Weiss, 1977dipyridamol + aspirincontrol66 (30/36) Exploratory
Encke IA, 1976dipyridamol + aspirinplacebo30 (21/9) Exploratory
Encke IB, 1976dipyridamol + aspirinplacebo96 (62/34) Exploratory